Bumper Offer - Urjas oil Just @ Rs. 1
Arifine 2.5 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Schizophrenia, Mania. Secondary and off-label uses of Arifine 2.5 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Arifine 2.5 Tablet. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Arifine 2.5 Tablet include Back Pain, Dizziness, Drowsiness. Some other side effects of Arifine 2.5 Tablet have been listed ahead. Usually, these side effects of Arifine 2.5 Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Arifine 2.5 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. Further, the section on Arifine 2.5 Tablet related warnings talks about Arifine 2.5 Tablet's effects on the liver, heart and kidney.
Arifine 2.5 Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Tardive Dyskinesia, Dementia as it can result in adverse effects. The section on Arifine 2.5 Tablet contraindications lists all such conditions.
Besides this, Arifine 2.5 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Arifine 2.5 Tablet is not safe while driving, and is is not addictive in nature.
Arifine 2.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Arifine 2.5 Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Arifine 2.5 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Arifine. It is best to stop taking Arifine immediately and inform your doctor if you notice any discomfort.
Is the use of Arifine 2.5 Tablet safe during breastfeeding?
Arifine should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Arifine 2.5 Tablet on the Kidneys?
There are no side effects of Arifine on the kidneys.
What is the effect of Arifine 2.5 Tablet on the Liver?
Arifine does not damage the liver.
What is the effect of Arifine 2.5 Tablet on the Heart?
Arifine has very mild side effects on the heart.
Arifine 2.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Arifine 2.5 Tablet unless your doctor advises you to do so -
Is this Arifine 2.5 Tablet habit forming or addictive?
No, there is no any evidence that Arifine 2.5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Arifine 2.5 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Arifine 2.5 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, Arifine 2.5 Tablet is useful in treating mental disorders.
Interaction between Food and Arifine 2.5 Tablet
Arifine 2.5 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Arifine 2.5 Tablet
Taking alcohol with Arifine 2.5 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Abilify® (aripiprazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 440,442
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 184-188
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Abilify® (aripiprazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 440,442
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 184-188
